Bovie Medical Corporation to Present at the JMP Securities Life Sciences Conference

CLEARWATER, Fla.--()--Bovie Medical Corporation (NYSEMKT:BVX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced that management will participate in the JMP Securities Life Sciences Conference at the St. Regis Hotel in New York, New York. Management will host a presentation with investors on Wednesday, June 21 at 12:00 p.m. Eastern Time.

A live audio webcast of the presentation will be provided under the ‘Company Events’ section of the Bovie Medical investor relations website at An archive of the webcast will be available for replay following the conferences.

About Bovie Medical Corporation:

Bovie Medical Corporation is a leading maker of medical devices and supplies as well as the developer of J-Plasma®, a patented plasma-based surgical product for cutting, coagulation and ablation of soft tissue. J-Plasma® utilizes a helium ionization process to produce a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents through the patient during surgery. Bovie Medical Corporation is also a leader in the manufacture of a range of electrosurgical products and technologies, marketed through both private labels and the Company's own well-respected brands (Bovie®, IDS™, ICON™ and DERM™) to distributors worldwide. The Company also leverages its expertise through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the Company's current and new products, please refer to the Investor Relations section of Bovie Medical Corporation at


Investor Relations Contact:
Westwicke Partners on behalf of Bovie Medical Corporation
Mike Piccinino, CFA

Recent Stories

RSS feed for Bovie Medical Corporation